Skip to main content

Find Clinical Trials

Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,005 public trials 1,840 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function

NCT02214147

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Miami, Florida, United States

Chicago, Illinois, United States

Ann Arbor, Michigan, United States

St Louis, Missouri, United States

View Trial Details

Completed

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

NCT00003245

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +36 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

PUVA Maintenance Therapy in Mycosis Fungoides

NCT01686594

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Medical University of Graz Graz, Austria

Department of Dermatology, Medical University of Innsbruck Innsbruck, Austria

Department of Dermatology, General Hospital of the City of Linz Linz, Austria

Department of Dermatology, Hospital Salzburg - Paracelsus Private Medical University Salzburg, Austria

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

NCT00002565

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

Faculdade de Medicina do ABC São Paulo, Brazil

Clinica Alemana Santiago, Chile

View Trial Details

Completed

Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT01769209

Conditions: B-cell Adult Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: Stanford University, School of Medicine Stanford, California, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT00003311

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis

NCT02458937

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +22 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

NCT00709592

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +36 more
Locations: Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

NCT01499147

Conditions: Acute Leukemia, Acute Myeloid Leukemia, Anemia, +51 more
Locations: University of Illinois at Chicago Medical Center Chicago, Illinois, United States

View Trial Details

Completed

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

NCT01313689

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations: Novartis Investigative Site Graz, Austria

Novartis Investigative Site Innsbruck, Austria

Novartis Investigative Site Linz, Austria

Novartis Investigative Site Salzburg, Austria

View all 80 locations

View Trial Details